BCL2 and neoplasm: For example, in BC, BAG3 up-regulates the expression levels of Bcl-2 and Bcl-xL by targeting HSP70/Mcl-1 signaling pathway and suppresses the chemoresistance of tumor cells, indicating that BAG3 may be a potential target for treating BC.25